These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8856787)

  • 1. Post-discharge prevention of deep vein thrombosis following total joint replacement.
    Fitzgerald RH
    Orthopedics; 1996 Aug; 19 Suppl():15-8. PubMed ID: 8856787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-discharge prevention of deep vein thrombosis following total joint replacement.
    Fitzgerald RH
    Orthopedics; 1996 Aug; 19():15-8. PubMed ID: 24826672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician practices in the prevention of deep vein thrombosis: the MassPRO DVT Study.
    Anderson FA; Audet AM
    Orthopedics; 1996 Aug; 19 Suppl():9-11. PubMed ID: 8856785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged prophylaxis in postoperative medicine.
    Bergqvist D
    Semin Thromb Hemost; 1997; 23(2):149-54. PubMed ID: 9200339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a universal protocol for deep vein thrombosis following orthopedic surgery: total knee arthroplasty.
    Sculco TP
    Orthopedics; 1996 Aug; 19 Suppl():6-8. PubMed ID: 8856784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The post-hospital discharge venous thrombosis risk of the orthopedic patient.
    Planes A; Vochelle N
    Orthopedics; 1997 Feb; 20 Suppl():18-21. PubMed ID: 9048403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
    Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F
    Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT; Hunt N; Strachan RK; Nicolaides AN
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
    Lassen MR; Borris LC
    Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin.
    Nilsson PE; Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlund U; Nicolas S; Nylander G
    Orthopedics; 1997 Feb; 20 Suppl():22-5. PubMed ID: 9048404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep vein thrombosis: beyond the operating table.
    Haas S
    Orthopedics; 2000 Jun; 23(6 Suppl):s629-32. PubMed ID: 10875426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lysis therapy in deep leg vein thrombosis and pulmonary embolism after hip surgery?].
    Kienast J; van de Loo J
    Dtsch Med Wochenschr; 1991 Apr; 116(17):676-7. PubMed ID: 2019244
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery.
    Glotzbecker MP; Bono CM; Harris MB; Brick G; Heary RF; Wood KB
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2915-21. PubMed ID: 19092624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended prophylaxis of venous thromboembolism in major orthopaedic surgery.
    Verhaeghe R
    Acta Orthop Belg; 2005 Jun; 71(3):255-9. PubMed ID: 16035696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.
    Garcia-Zozaya I
    J Ky Med Assoc; 1998 Apr; 96(4):143-8. PubMed ID: 9577110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building effective prophylaxis of deep vein thrombosis in the outpatient setting.
    Agnelli G; Taliani MR; Verso M
    Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S29-35. PubMed ID: 10493228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
    Dahl OE; Gudmundsen TE; Bjørnarå BT; Solheim DM
    Acta Orthop Scand; 2003 Jun; 74(3):299-304. PubMed ID: 12899550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.